These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21507937)

  • 1. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
    Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
    J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
    LaChapelle S; Tweten RK; Hotze EM
    J Biol Chem; 2009 May; 284(19):12719-26. PubMed ID: 19293153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.
    Johnson S; Brooks NJ; Smith RA; Lea SM; Bubeck D
    Cell Rep; 2013 May; 3(5):1369-77. PubMed ID: 23665225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
    Soltani CE; Hotze EM; Johnson AE; Tweten RK
    J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
    Hughes TR; Ross KS; Cowan GJ; Sivasankar B; Harris CL; Mitchell TJ; Morgan BP
    Mol Immunol; 2009 Apr; 46(7):1561-7. PubMed ID: 19200600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
    Boyd CM; Parsons ES; Smith RA; Seddon JM; Ces O; Bubeck D
    Sci Rep; 2016 Dec; 6():38446. PubMed ID: 27910935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of ILY, VLY and Sm-hPAF interaction with human CD59.
    Kawaguchi Y; Tabata A; Nagamune H; Ohkura K
    Anticancer Res; 2013 Jul; 33(7):2901-4. PubMed ID: 23780977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
    Giddings KS; Zhao J; Sims PJ; Tweten RK
    Nat Struct Mol Biol; 2004 Dec; 11(12):1173-8. PubMed ID: 15543155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
    Scibek JJ; Plumb ME; Sodetz JM
    Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
    Zilnyte M; Venclovas Č; Zvirbliene A; Pleckaityte M
    Toxins (Basel); 2015 Jan; 7(1):110-28. PubMed ID: 25590277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
    Slade DJ; Chiswell B; Sodetz JM
    Biochemistry; 2006 Apr; 45(16):5290-6. PubMed ID: 16618117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
    Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.
    Lovelace LL; Cooper CL; Sodetz JM; Lebioda L
    J Biol Chem; 2011 May; 286(20):17585-92. PubMed ID: 21454577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the CD59-C9 binding interaction.
    Huang Y; Qiao F; Abagyan R; Hazard S; Tomlinson S
    J Biol Chem; 2006 Sep; 281(37):27398-404. PubMed ID: 16844690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis for Receptor Recognition by the Human CD59-Responsive Cholesterol-Dependent Cytolysins.
    Lawrence SL; Gorman MA; Feil SC; Mulhern TD; Kuiper MJ; Ratner AJ; Tweten RK; Morton CJ; Parker MW
    Structure; 2016 Sep; 24(9):1488-98. PubMed ID: 27499440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for membrane attack complex inhibition by CD59.
    Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
    Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y; Fedarovich A; Tomlinson S; Davies C
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution structures of bacterially expressed soluble human CD59.
    Leath KJ; Johnson S; Roversi P; Hughes TR; Smith RA; Mackenzie L; Morgan BP; Lea SM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug; 63(Pt 8):648-52. PubMed ID: 17671359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.